Immutep与Dr. Reddy's达成战略合作 推广创新肿瘤药物Eftilagimod Alfa

投资观察
Dec 08, 2025

12月8日 - Immutep Ltd宣布,Immutep与Dr. Reddy’s达成了战略合作协议,共同推广一种创新的肿瘤药物Eftilagimod Alfa。根据协议,Immutep将获得2,000万美元的预付款,以及最高可达3.495亿美元的额外资金。此外,Dr. Reddy's将获得在北美、欧洲、日本及大中华区以外所有国家对Eftilagimod Alfa的独家权利。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10